Related Experiment Video
Updated: Nov 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Early prediction keys for COVID-19 cases progression: A meta-analysis
Mostafa M Khodeir1, Hassan A Shabana2, Abdullah S Alkhamiss3
1Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt; Department of Pathology, College of Medicine, Qassim University, Buraidah, Qassim, Saudi Arabia.
Biomarkers like C-reactive protein and interleukin-6, along with factors such as age and diabetes, can predict severe COVID-19 progression. This meta-analysis identifies key indicators for disease severity and timely treatment guidance.
Area of Science:
- Infectious Diseases
- Clinical Diagnostics
- Biomarker Research
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to millions of deaths globally.
- Predicting COVID-19 case progression remains challenging, with limited consensus on reliable predictive factors.
- Existing studies report varied laboratory values for predicting severe disease progression.
Purpose of the Study:
- To systematically analyze biomarker values and risk factors associated with COVID-19 severity.
- To evaluate the correlation between specific biomarkers and the progression of COVID-19 from mild/moderate to severe/critical cases.
- To identify potential predictive indicators for COVID-19 case progression.
Main Methods:
- A meta-analysis was conducted on relevant articles identified through eight databases.
- Eligibility criteria for study selection were defined using a PICO model.
- The analysis focused on biomarkers and risk factors predicting progression to severe and critical COVID-19.
Main Results:
- Twenty-two articles were included in the meta-analysis.
- High cut-off values for C-reactive protein, interleukin-6, LDH, neutrophils, %PD-1 expression, D-dimer, creatinine, AST, and cortisol were linked to severe/critical COVID-19.
- Low lymphocyte count, low albumin levels, older age, hypertension, diabetes, and COPD were significantly correlated with disease progression (p < 0.05).
Conclusions:
- This meta-analysis provides initial cut-off reference values for predicting COVID-19 progression.
- Further large-scale studies are necessary to establish clearer threshold values for predicting progression.
- Additional biomarker testing could aid in developing scoring systems for prediction and guiding timely treatment.
Related Concept Videos
Steps in Outbreak Investigation
Single Nucleotide Polymorphisms-SNPs
Statistical Methods for Analyzing Epidemiological Data
Causality in Epidemiology
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Residuals and Least-Squares Property
If the observed data point lies above the line, the residual is positive, and the line underestimates the actual data value for y. If the observed data point lies below the line, the residual is negative, and the line overestimates the actual data value for y.
The process of fitting the best-fit...

